Axsome Therapeutics financial statements

액섬 테라퓨틱스NASDAQ:AXSM · Nasdaq · Healthcare · sector #13
$177.08-1.21%
2026-10-05 close

Axsome Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $386M. 2024 operating profit was −$281M.

Reported results

Axsome Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q